Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.40
-0.07 (-1.08%)
At close: Jul 24, 2025, 4:00 PM
6.37
-0.03 (-0.47%)
After-hours: Jul 24, 2025, 5:02 PM EDT
Bioventus Employees
Bioventus had 930 employees as of December 31, 2024. The number of employees decreased by 40 or -4.12% compared to the previous year.
Employees
930
Change (1Y)
-40
Growth (1Y)
-4.12%
Revenue / Employee
$610,429
Profits / Employee
-$33,644
Market Cap
424.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BVS News
- 2 months ago - Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Bioventus Reports First Quarter Financial Results - GlobeNewsWire
- 3 months ago - Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025 - GlobeNewsWire
- 4 months ago - Bioventus Inc. (BVS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million - Benzinga
- 4 months ago - Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 months ago - Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - GlobeNewsWire
- 7 months ago - Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - GlobeNewsWire